BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37231916)

  • 21. Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003.
    Riou-Gotta MO; Fournier E; Mermet I; Pelletier F; Humbert P; Danzon A; Aubin F
    Leuk Lymphoma; 2008 Aug; 49(8):1537-44. PubMed ID: 18766967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associated Hematolymphoid Malignancies in Patients With Lymphomatoid Papulosis: A Canadian Retrospective Study.
    AbuHilal M; Walsh S; Shear N
    J Cutan Med Surg; 2017; 21(6):507-512. PubMed ID: 28614957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous lymphoma: Kids are not just little people.
    Ferenczi K; Makkar HS
    Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study.
    D'Onghia M; Cartocci A; Calabrese L; Maio D; Sirchio A; Erasti M; Tognetti L; Rubegni P; Bocchia M; Cencini E; Fabbri A; Cinotti E
    Curr Oncol; 2023 Nov; 30(11):9813-9823. PubMed ID: 37999132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.
    Kothari R; Szepietowski JC; Bagot M; Sandhu S; Patil A; Grabbe S; Goldust M
    Int J Dermatol; 2022 Dec; 61(12):1458-1466. PubMed ID: 35193164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
    Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous lymphomas other than mycosis fungoides in Singapore: a clinicopathological analysis using recent classification systems.
    Tan SH; Sim CS; Ong BH
    Br J Dermatol; 2003 Sep; 149(3):542-53. PubMed ID: 14510987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
    Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
    Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
    Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
    J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cutaneous lymphomas: new entities and rare variants].
    Kempf W; Mitteldorf C
    Pathologe; 2015 Feb; 36(1):62-9. PubMed ID: 25589355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous nonmycotic T- and natural killer/T-cell lymphomas: diagnostic challenges and dilemmas.
    Chuang SS; Ko YH
    J Am Acad Dermatol; 2014 Apr; 70(4):724-735. PubMed ID: 24521829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
    Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
    J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The different faces of mycosis fungoides: results of a single-center study.
    Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
    Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.
    Dobos G; de Masson A; Ram-Wolff C; Beylot-Barry M; Pham-Ledard A; Ortonne N; Ingen-Housz-Oro S; Battistella M; d'Incan M; Rouanet J; Franck F; Vignon-Pennamen MD; Franck N; Carlotti A; Boulinguez S; Lamant L; Petrella T; Dalac S; Joly P; Courville P; Rivet J; Dereure O; Amatore F; Taix S; Grange F; Durlach A; Quéreux G; Josselin N; Moulonguet I; Mortier L; Dubois R; Maubec E; Laroche L; Michel L; Templier I; Barete S; Nardin C; Augereau O; Vergier B; Bagot M;
    Br J Dermatol; 2021 Jun; 184(6):1059-1067. PubMed ID: 33131055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course.
    Macagno N; Mastorino L; Rubatto M; Avallone G; Merli M; Agostini A; Fava P; Ribero S; Quaglino P
    J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2388-2392. PubMed ID: 35881645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Cutaneous Extranodal Natural Killer/T-Cell Lymphoma Misdiagnosed as Peripheral T-Cell Lymphoma: The Importance of Consultation/Referral and Inclusion of EBV In Situ Hybridization for Diagnosis.
    Win KT; Liau JY; Chen BJ; Takata K; Chen CY; Li CC; Hsiao CH; Chuang SS
    Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):105-11. PubMed ID: 25710587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous lymphoma in Japan, 2012-2017: A nationwide study.
    Fujii K; Hamada T; Shimauchi T; Asai J; Fujisawa Y; Ihn H; Katoh N
    J Dermatol Sci; 2020 Mar; 97(3):187-193. PubMed ID: 32033869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic analysis of cutaneous lymphoma in taiwan: a high frequency of extranodal natural killer/t-cell lymphoma, nasal type, with an extremely poor prognosis.
    Liao JB; Chuang SS; Chen HC; Tseng HH; Wang JS; Hsieh PP
    Arch Pathol Lab Med; 2010 Jul; 134(7):996-1002. PubMed ID: 20586627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
    Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Item 164--Malignant lymphomas: cutaneous lymphomas].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A164-6. PubMed ID: 23176840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.